A doctor-blade coating of methylammonium lead iodide (MAPbI 3 ) solar cells with a PCE of 15.1% was first reported. [4c] The doctor-blading gives a new degree of film formation controlling with the independently controlled temperature compared to the spin-coating process, which allows the large grain formation as well as photonic grain structure formation by controlling the evaporation and fluid dynamics of the precursor solution. [4d] This temperature controlling is not achievable in regular spin-coating process, and is much simpler than the substrate temperature controlling in film deposition by thermal evaporation. The coating process with higher temperature also allows the formation of stable mixed cation perovskite directly, which is however difficult to form by thermal annealing process after film deposition by spin-coating. [4b,6] The incorporation of formamidinium cation (FA + ) into MAPbI 3 extended the absorption spectrum of MAPbI 3 and thus increased the short circuit current density (J sc ). A doctor-bladed MA 0.6 FA 0.4 PbI 3 thin film showed an absorption onset of 850 nm and the corresponding solar cell achieved a PCE of 18.3%. [4b] However, the PCEs of OIHP solar cell via scalable deposition methods still lag behind the 19%-20% PCEs of spin-coated devices with similar composition and device structure. [7] On the other hand, although the temperature of 150 °C in doctor-blade coating of MA 0.6 FA 0.4 PbI 3 is still compatible with flexible device fabrication, it is approaching the boiling point of dimethylformamide (DMF, 153 °C), which may cause potential safety issues in solar panel fabrication. [4b,8] Hence, it is desirable to reduce the coating temperature. The reduction of blading temperature also reduces the energy cost for the blading process.
Organic-inorganic halide perovskite (OIHP) solar cells with efficiency over 18% power conversion efficiency (PCE) have been widely achieved with lab scale spin-coating method which is however not scalable for the fabrication of large area solar panels. The PCEs of OIHP solar cells made by scalable deposition methods, such as doctor-blading or slot-die coating, have been lagging far behind than spin-coated devices. In this study the authors report composition engineering in doctor-bladed OIHP solar cells with p-i-n planar heterojunction structure to enhance their efficiency. Phase purer OIHP thin films are obtained by incorporating a small amount of cesium (Cs + ) and bromine (Br − ) ions into perovskite precursor solution, which also reduces the required film formation temperature. Pinhole free OIHP thin films with micrometersized grains have been obtained assisted by a secondary grain growth with added methylammonium chloride into the precursor solution. The OIHP solar cells using these bladed thin films achieved PCEs over 19.0%, with the best stabilized PCE reaching 19.3%. This represents a significant step toward scalable manufacture of OIHP solar cells.
Methylammonium chloride (MACl) was added into precursor solutions to increase the film coverage and grain sizes via a secondary grain growth. [11] As a result, a pinhole free and smooth MA 0.6 FA 0.38 Cs 0.02 PbI 2.975 Br 0.025 film was obtained via doctorblade coating at a lower blading temperature of 120 °C, leading to an improved stabilized PCE of 19.3%.
The doctor-blade coating of the OIHP films is illustrated in Figure 1a , which is similar to the process what we previous reported. [4b,c] Briefly, different OIHP precursor solutions were mixed in certain ratios and the as-prepared precursor solution was dropped onto heated substrates at a preset temperature, which was followed by spreading the solution from the front to the end of the substrate by moving the blade and the blading process and parameters are described in detail in the Experimental Section. The thickness of the bladed films was controlled by the concentration of the precursor solution as well as the spacing between the blade edge and the substrate. The precursor solution dried in seconds, and the substrates were removed quickly from the hotplate after the blading. The precursor solutions were prepared by mixing as-prepared MAPbI 3 films were further characterized. It is noted that the bandgap of the perovskites was indeed increased by Cs + incorporation, nevertheless, it brings more stable perovskite films. Besides the film coverage, the phase impurity of the doctor-bladed OIHP films was also considered in order to achieve highly efficient solar cells. Photoluminescence (PL) spectroscopy has been well established as a simple and effective approach to characterize phase segregation in mixed cation/anion OIHP films. [12] To examine the phase purity, PL spectra were recorded for MA 0. 6 Figure 1c ) and this spectrum can be well fitted by a single Gaussian peak (blue dash line Figure 1c) study, while we tried to use as low temperature as possible in this study. [4b] X-ray diffraction (XRD) characterization also confirmed the phase separation in MA 0.6 FA 0.4 PbI 3 films. As shown in Figure 1d , a relative strong lead iodide (PbI 2 ) (100) peak was observed in the XRD spectrum of MA 0.6 FA 0.4 PbI 3 film indicating a PbI 2 impurity in the MA 0.6 FA 0.4 PbI 3 film at a blading temperature of 120 °C. However, this PbI 2 (100) peak was not observed in the MA 0.6 FA 0.4 PbI 3 film at a higher blading temperature of 150 °C which exclude the possibility of decomposition during the doctor-blade coating.
[4b] The significant reduction of the PbI 2 (100) peak intensity in the XRD spectrum of MA 0.6 FA 0.38 Cs 0.02 PbI 2.975 Br 0.025 film suggests a suppression of phase separation or decomposition, which agrees well with the result of PL study and previous report. [6,9b,13] Though a small amount of PbI 2 still remained in perovskite films, it did not impact the device efficiency, which might be due to the reported self-passivation of the perovskite films by the wide bandgap PbI 2 . [14] By Figure 2c . The formation of pinholes can be explained by the dynamic process of film drying and convection of the OIHP solution during the blading process. At a lower blading temperature, the solvent evaporation slows down and the solutes (OIHP materials and nucleus in this case) can be quickly flushed away from the domain boundaries and thus leave pinholes. This does not occur at higher blading temperature because the quicker evaporation of solvent could freeze the solute at the domain boundaries. By introducing MACl into the precursor solution the crystallization can be retarded, because a secondary grain growth process can occur. The MACl incorporation introduces a Cl-rich intermediate phases in the solid-state perovskite films, which are dispersed in the Cl-poor phase. [11, 15] Though this Cl-rich phase will eventually turn to Cl-poor phase after the evaporation of MACl during thermal annealing, this process effectively slowed down grain growth and helps the formation of continuous films. By adding 5 mol% of MACl into the precursor solution, the coverage of MA 0. 6 Figure 2b and 100% coverage was achieved as Figure 2d suggests.
After achieving a phase purer and pinhole free doctor-bladed perovskite film at a blading temperature of 120 °C, we evaluate the influence of composition engineering on the device performance. A p-i-n planar heterojunction structure of indium tin oxide (ITO)/poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine]-(PTAA)/perovskite/C 60 /2,9-dimethyl-4,7-di-phenyl-1,10-phenanthroline (BCP)/copper(Cu) was employed which is shown in Figure S1 in the Supporting Information. Hence, the enhancement of device performance should not be ascribed to the film morphology. The enhanced performance can be explained by the better phase purity after Br − incorporation which stabilize the black phase of FAPbI 3 films.
[9b] Further increase the molar ratio of Br − up to 12.5 mol% in the doctor-bladed OIHP films did not lead to enhancement of PCE, as shown by the J-V curves in Figure S2a in the Supporting Information, most likely because a higher Br − ratio leads to a larger bandgap and also instability of OIHP films under illumination. [12] Hence the molar ratio of Br − in the OIHP precursor solution was fixed to 2.5 mol%. Next, Cs + was incorporated into the MA 0. 6 precursor solution to further improve the PCE. In the meantime, the function of Cl − incorporation was evaluated. The molar ratio of the Cs + in the precursor solution was varied from 1 mol% to 4 mol%, and the device performance of the corresponding solar cells are summarized in Figure 5c with the corresponding J-V curves shown in Figure S2b in the Supporting Information. The highest PCE of 19.2% was achieved at a Cs + ratio of 2 mol% but only with MACl additives. As shown by the J-V curves in Figure 3c , adding Cs + further increased the PCE of the device. The increase of V oc and reduction of dark current in the device with MACl shown in Figure 3c ,d suggest the importance of increasing film coverage and grain size via MACl additives.
To better characterize the device performance, the J-V curves of the device made of a MA 0.6 FA 0.38 Cs 0.02 PbI 2.975 Br 0.025 : 5 mol% MACl film was measured with both "forward" and "reverse" scanning modes with a scanning rate of 0.1 V s −1 . As shown in Figure 4a , no obvious hysteresis was observed. One of the best devices achieved a PCE of 19.5% with a FF of 77%, a J sc of 23.1 mA cm −2 and a V OC of 1.09 V. Figure 4b shows the stabilized photocurrent density of this device measured at 0.9 V, giving a stabilized PCE of 19.3%. Figure 4c shows the external quantum efficiency (EQE) of this device. The integrated J sc from EQE is in good agreement with the measured J sc under simulated AM 1.5 G illumination shown in Figure 4a The PL spectra in Figure 1c show that the addition of 2 mol% Cs + and 2.5 mol% Br − is sufficient to eliminate detrimental effect to device performance from the phase impurity of MA 0.6 FA 0.4 PbI 3 . To directly verify it, we measured the effect of the eliminated impurity phase on carrier recombination process and charge trap density in the doctor-bladed OIHP films. Again, in the precursor solution the MACl ratio was fixed to 5 mol%, the Br − ratio was fixed to 2.5 mol% and Cs + ratio was varied from 1 to 4 mol% to obtain the doctor-bladed films and solar cells. Time corrected single photon counting (TCSPC) was performed to clarify the influence of Cs + ratio in the precursor solution to the recombination dynamics of the corresponding films, and the PL decay curves of these films with different Cs + ratio were shown in Figure 5a . When the Cs + ratio in the precursor solution was lower than 2 mol%, the carrier recombination lifetime of the charge carriers in the doctor-bladed films increased with the Cs + ratio. However, when the Cs + ratio in the precursor solution further increased, the carrier recombination lifetime in the doctor-bladed films decreased. The carrier recombination lifetime was in good agreement with the device performance from doctor-bladed OIHP films with different carrier recombination lifetimes. A possible reason for the variation of carrier recombination lifetime is the different trap density of states (tDOS) of the doctor-bladed OIHP films.
Thermal admittance spectroscopy (TAS) was performed to obtain the tDOS of the doctor-bladed OIHP solar cells with different Cs + ratio, [16] and the tDOS of the MA 0.6 FA 0.4 PbI 3 solar cell was also recorded as a reference. As shown in Figure 5b . After incorporating 2 mol% Cs + , the tDOS was reduced by over tenfold in the trap depth of 0.4-0.55 eV. The higher tDOS of MA 0.6 FA 0.4 PbI 3 solar cell may originate from the lower bandgap OIHP generated under illumination. Hence, incorporating less than 2 mol% Cs + into the precursor solution to suppress the phase separation leads to the reduction of tDOS in the corresponding solar cells. However, when the Cs + ratio in the OIHP precursor solution was further increased over 2 mol%, the tDOS at a range of 0.4-0.55 eV of the doctor-bladed OIHP solar cells increased which may be caused by strains. [17] When a higher molar ratio of Cs + was incorporated into the OIHP precursor solution, a reduction of lifetime was observed in recent report. [17] Another method of evaluating charge trap density in the band tail is to measure the Urbach energy. [18] The calculated Urbach energies from EQE curves are also summarized in Figure 5c . The Urbach energy for MA 0.6 FA 0.4 PbI 3 film is 33 meV, and incorporating 1 mol% of Cs + into the OIHP thin film reduced the Urbach energy by ≈10 meV. The Urbach energy reached a minimum value of 17 meV with a Cs + ratio of 2 mol%, which is the smallest among all the perovskite films measured so far and demonstrated the enhanced phase purity of these films after dedicated composition engineering. Figure 5c also shows a clear correlation between the carrier radiative recombination lifetime, Urbach energy, and device efficiency at different Cs + ratio. Basically, a proper amount of Cs + in the films increased the carrier radiative recombination lifetime, reduced the Urbach energy, and improved the device efficiency.
In conclusion, highly efficient doctor-bladed OIHP solar cells were fabricated at a blading temperature of 120 °C by mixing Cs + cation and Br − anion into OIHP precursor solution. By preventing the phase separation under illumination and minimizing the charge traps in the OIHP films, the electronic properties of these OIHP films were significantly improved, which resulted in an impressive enhancement in device performance. The best device from the doctor-bladed MA 0.6 FA 0.38 Cs 0.02 PbI 2.975 Br 0.025 films achieved a stabilized PCE of 19.3%, and showed less than 10% degradation after storage for one month.
Experimental Section
Perovskite Precursor Solution Preparation: Methylammonium iodide and PbI 2 were dissolved in DMF in equal molar and filtered through a polytetrafluoroethylene filter (0.25 µm) to form the MAPbI 3 precursor solution (1 m). Formamidinium iodide and PbI 2 were dissolved in DMF in equal molar to form the FAPbI 3 precursor solution (1 m). MABr and PbBr 2 were dissolved in DMF in equal molar to form the MAPbBr 3 precursor solution (1 m). CsI and PbI 2 were dissolved in a mixed solvent of DMF and DMSO (DMF:DMSO = 4:1 in volume ratio) in equal molar to form the CsPbI 3 precursor solution (0.85 m). Then the four solutions were mixed in certain ratios to form the precursor solutions and before use phosphatidylcholine DMF solution (0.025 wt%) was added into the precursor solution to help increasing the affinity of the precursor solution to the nonwetting hole transport layer.
Device Fabrication: PTAA (Sigma-Aldrich) in toluene (2 mg mL −1 ) was spin-coated onto the ITO substrates at 4000 rpm for 20 s and annealed at 100 °C for 10 min. The as-prepared perovskite precursor solution (10-15 µL) was dropped onto PTAA-covered ITO substrates on a hot plate with temperature from 100 to 140 °C. Right after the dripping of precursor solution, the perovskite precursor solution was swiped linearly by a glass blade at a speed of 7.5 mm s −1 . The as-prepared perovskite films were then annealed at 100 °C for 30 min. All of the above experiments were conducted in a N 2 filled glove box. The top-view SEM images of the MA 0.6 FA 0.38 Cs 0.02 PbI 2.975 Br 0.025 films blading at different temperature are shown in Figure S4 in the Supporting Information. Finally, C 60 (30 nm), BCP (8 nm), and Cu (80 nm) were deposited by thermal evaporation sequentially.
I-V and EQE measurements: AM 1.5G irradiation (100 mW cm −2 ) with a xenon-lamp-based solar simulator (Oriel 67005, 150W Solar Simulator) was used as the illumination source. A Schott visible-color glassfiltered (KG5 color-filtered) Si diode (Hamamatsu S1133) was used to calibrate the light intensity before photocurrent measurement. Keithley 2400 Source-Meter was used for recording in the I-V measurement. Unless otherwise stated, the scanning direction for I-V measurement was from negative bias to positive bias. The voltage scanning rate was 0.1 V s −1 . The steady-state J sc was measured by recording device Thin Film Characterization: For thin film characterization, the perovskite thin films were bladed on precleaned glass with 15 min UV-Ozone treatment. The same precursor solutions as device fabrication were used for blading thin films. After blading, the thin films were annealed at 100 °C for 30 min and 10 mg mL −1 poly(methyl methacrylate) solution were spin-coated onto each substrate to exclude the influence of oxygen and moisture during the characterization. XRD spectra were measured by a Bruker D8 Discover Diffractometer with Cu Kα radiation (1.5406 Å). Top-view SEM images were obtained with a Quanta 200 FEG ESEM. The PL spectrum was measured by iHR320 photoluminescence spectroscopy at room temperature. A 532 nm green laser with an intensity of 100 mW cm −2 from Laserglow Technologies was used as excitation source in PL measurement. The time-resolved photoluminescence was obtained via the DeltaPro with a pulsed laser source at 406 nm (Horiba NanoLED 402-LH; pulse width <200 ps, 20 pJ per pulse, ≈1 mm 2 in spot size), and the signal was recorded using time corrected TCSPC. The samples were excited from the perovskite side under ambient conditions.
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